ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1060

The View of Healthy Persons on the Impact of Spondyloarthritis on Functioning and Health: Results of a Best-Worst Scaling Based on the ASAS Health Index

Ivette Essers1,2, Mickaël Hiligsmann3, Uta Kiltz4, Nick Bansback5, Juergen Braun4, Désirée van der Heijde6 and Annelies Boonen1,7, 1School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, Netherlands, 2Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 3Department of Health Services Research, University of Maastricht, Maastricht, Netherlands, 4Rheumazentrum Ruhrgebiet, Herne, Germany, 5School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada, 6Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 7Maastricht University Medical Center, Maastricht, Netherlands

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Health, outcomes and spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Clinical Aspects and CoMorbidities

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:
The ASAS Health Index (HI) is a disease-specific questionnaire (QoL) for
patients with spondyloarthritis (SpA) aiming to measure functioning and health. The ASAS HI can serve as
a starting point to develop a disease-specific utility reflecting the value or
preference for health states specific for patients with SpA. Although it is
important to measure health utility from the perspective of the patient, it is
recommended worldwide to base decisions about resource allocation on utilities
representing the perspective of the general population. In a first step towards
a disease specific utility for the societal perspective, it is necessary to
know which of the 17 aspects of health impairments included in the ASAS HI have
the most influence on health according to subjects from general population and
to understand whether there are differences in ratings among European
countries.

Methods:
An online survey was performed to conduct a best-worst experiment (BWS) based
on the items of the ASAS HI in a random sample of persons from the general
population from the UK, France, Germany, the Netherlands, Spain and Italy. In
the BWS experiment, persons answered 17 choice
tasks, each consisting each time of 4 different items of the ASAS HI. In each
task, persons had to indicate which item they considered the most important and
the least important for functioning and health. The mean relative
importance for each item of the ASAS HI could then be generated using the
estimated hierarchical Bayes method.
Differences in subgroups by country, gender and age were explored. Construction
of the tasks and data-analysis were performed using the Sawtooth software.

Results:
In total, 3,039
(around 500/country) persons from the general population (age 46.5 years (SD
15.2), 1556 women (52.2%)) contributed to the analysis. The 5 most important aspects
were pain (9.97, 95%-CI 9.79 to 10.14), sleeping (9.50, 95%-CI 9.31 to 9.69),
being exhausted (8.03, 95%-CI 7.88 to 8.19),
overcome difficulties (7.55, 95%-CI 7.39 to 7.70), and being able to concentrate
(6.78, 95%-CI 6.63 to 6.93). The 5 least important items were washing hair
(2.28, 95%-CI 2.18 to 2.39), running (3.65, 95-CI 3.50 to 3.80), driving (3.94,
95%-CI 3.80 to 4.08), contact with people (4.16, 95%-CI 4.02 to 4.29), and
travelling (4.42, 95-CI 4.29 to 4.56).
Figure 1 shows results and illustrates the consistency of findings across
countries, age-categories and sex.

Conclusion: This study provides information of
the relative impact of the items of the ASAS HI on overall health from the
societal perspective. The general population states that pain, sleeping problems
and being exhausted are the most important aspects of SpA that influence
functioning and health. The results were comparable across sex, age and
countries. This study is the first step towards a disease specific utility for
health in SpA.

 

 


Disclosure: I. Essers, None; M. Hiligsmann, None; U. Kiltz, None; N. Bansback, None; J. Braun, Abbvie (Abbott), Amgen, BMS, Boehringer, Celgene, Celltrion, Centocor, Chugai, EBEWE Pharma, Medac, MSD (Schering-Plough), Mundipharma, Novartis, Pfizer (Wyeth), Roche, Sanofi-Aventis and UCB, 9,Abbvie (Abbott), Amgen, BMS, Boehringer, Celgene, Celltrion, Centocor, Chugai, EBEWE Pharma, Medac, MSD (Schering-Plough), Mundipharma, Novartis, Pfizer (Wyeth), Roche, Sanofi-Aventis and UCB, 9,Abbvie (Abbott), Amgen, BMS, Boehringer, Celgene, Celltrion, Centocor, Chugai, EBEWE Pharma, Medac, MSD (Schering-Plough), Mundipharma, Novartis, Pfizer (Wyeth), Roche, Sanofi-Aventis and UCB, 5; D. van der Heijde, None; A. Boonen, None.

To cite this abstract in AMA style:

Essers I, Hiligsmann M, Kiltz U, Bansback N, Braun J, van der Heijde D, Boonen A. The View of Healthy Persons on the Impact of Spondyloarthritis on Functioning and Health: Results of a Best-Worst Scaling Based on the ASAS Health Index [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-view-of-healthy-persons-on-the-impact-of-spondyloarthritis-on-functioning-and-health-results-of-a-best-worst-scaling-based-on-the-asas-health-index/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-view-of-healthy-persons-on-the-impact-of-spondyloarthritis-on-functioning-and-health-results-of-a-best-worst-scaling-based-on-the-asas-health-index/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology